HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer. [electronic resource]
- Molecular cancer therapeutics 11 2019
- 2135-2145 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1538-8514
10.1158/1535-7163.MCT-19-0455 doi
Animals Cell Line, Tumor Drug Resistance, Neoplasm ErbB Receptors--genetics Gene Expression Regulation, Neoplastic Humans MAP Kinase Signaling System Male Mice Phosphatidylinositol 3-Kinases--metabolism Receptor, ErbB-2--genetics Stomach Neoplasms--drug therapy TOR Serine-Threonine Kinases--metabolism Trastuzumab Up-Regulation